A bill to amend the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts relating to dietary supplements.
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S3081)
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™This Senate bill, numbered 4215 in the 118th Congress, proposes amendments to the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts specifically related to dietary supplements. The bill aims to enhance regulatory oversight by defining additional illegal activities concerning dietary supplements. As of April 30, 2024, the bill was read twice and referred to the Senate Committee on Health, Education, Labor, and Pensions but has since failed or expired. No full bill text or official summary is available to provide further details on the specific prohibited acts or enforcement mechanisms.
S.4215 sought to strengthen regulation of dietary supplements by adding new prohibited acts under existing federal law, but it did not advance beyond committee referral and has expired.
- The bill intends to amend the Federal Food, Drug, and Cosmetic Act to address dietary supplements.
- It proposes establishing new prohibited acts related to dietary supplements, though specifics are not provided in the available text.
- The bill was referred to the Senate Committee on Health, Education, Labor, and Pensions but did not progress further and is now classified as failed or expired.
['Consumers of dietary supplements who may gain from enhanced protections against unsafe or misleading products.', 'Regulatory agencies such as the Food and Drug Administration (FDA) that oversee dietary supplement safety and compliance.', 'Healthcare providers who rely on accurate supplement information for patient care.']
['Lack of detailed text limits understanding of enforcement scope and resource requirements for implementation.', 'Potential increased regulatory burden on dietary supplement manufacturers and distributors.', 'Unclear how new prohibited acts would be defined and enforced, which may affect legal clarity and compliance.']
The bill was introduced in the Senate during the 118th Congress and referred to the Committee on Health, Education, Labor, and Pensions. It did not advance beyond committee referral and is now considered failed or expired. No further legislative actions or debates are recorded in the provided data.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential improvement in consumer safety and confidence in dietary supplements if new prohibited acts effectively reduce harmful or deceptive products.', 'Possible market adjustments by dietary supplement companies to comply with new regulations, which could affect product availability and pricing.', 'Increased workload for regulatory agencies tasked with enforcing new provisions.']
The absence of a full bill text and official summary limits comprehensive analysis. Transparency would be improved by providing detailed legislative language and clear definitions of the new prohibited acts. Monitoring the bill's referral and expiration status is important for understanding legislative priorities and regulatory developments in dietary supplement oversight.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.